Nick D. Jones

5.3k citations
68 papers · 4.1k · 5 hit papers · h-index 29

Impact in

    • Renal Transplantation Outcomes and Treatments
  • Immunology top 2%
    • T-cell and B-cell Immunology
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses

Papers in

    • T-cell and B-cell Immunology 32
    • Immune Cell Function and Interaction 30
    • Immunotherapy and Immune Responses 23
    • Renal Transplantation Outcomes and Treatments 3

Nick D. Jones

68 papers receiving 4.0k citations

Nick D. Jones's Hit Papers

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial 2022 · 282 citations
2820+1+3Years since publication100200300400

Peers

Nick D. Jones
Comparison fields: 5 of 126
  • Transplantation 308
  • Immunology 1.4k
  • Infectious Diseases 993
  • Neurology 402
  • Applied Microbiology and Biotechnology 51
Replace Anna K. Reed with:
Anna K. Reed United Kingdom
Elizabeth C. Rosser United Kingdom
Eun‐Suk Kang South Korea
José Laurent Cohen France
Leland Shapiro United States
Marie‐Charlotte Brüggen Switzerland
Jan C. Grutters Netherlands
Paul A. Reyfman United States
Jason Y. Adams United States
Hans J. P. M. Koenen Netherlands
Nick D. Jones relative to Anna K. Reed United Kingdom Anna K. Reed's profile →
Citations per field
00.5×2×2.9×
Anna K. Reed · 1×
Citations per year

Countries citing papers authored by Nick D. Jones

Since Specialization
Citations

This map shows the geographic impact of Nick D. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick D. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick D. Jones more than expected).

Fields of papers citing papers by Nick D. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick D. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick D. Jones. The network helps show where Nick D. Jones may publish in the future.

Co-authors

The 25 scholars most cited alongside Nick D. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nick D. Jones Line = papers co-authored together Nick D. Jones links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021403
2
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Hit paper breakdown →
2021381
3
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
4
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Hit paper breakdown →
2022230
5
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021211
6 2015187
7 2007182
8 2009166
9 2010156
10 2002152
11 2001146
12 2015144
13 2000137
14
The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
199595
15 200693
16 202383
17 201480
18 200766
19 201161
20 201261

About Nick D. Jones

Nick D. Jones is a scholar working on Immunology, Transplantation, Infectious Diseases, Emergency Medical Services and Epidemiology, having authored 68 papers that have together received 4.1k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (32 papers), Immune Cell Function and Interaction (30 papers), Immunotherapy and Immune Responses (23 papers), Cytomegalovirus and herpesvirus research (6 papers), CAR-T cell therapy research (3 papers), Renal Transplantation Outcomes and Treatments (3 papers), Patient Safety and Medication Errors (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Transplantation (308 citations), Immunology (1.4k citations), Infectious Diseases (993 citations), Neurology (402 citations) and Applied Microbiology and Biotechnology (51 citations). Nick D. Jones has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Kathryn J. Wood, André van Maurik, Matthew O. Brook, Peter J. Morris, Manuela Carvalho‐Gaspar, Masaki Hara, Andrew Bushell, Andrew L. Mellor, Bernd M. Spriewald and Mohamed H. Sayegh. Their work appears in journals such as Transplantation, The Journal of Immunology, The Lancet, European Journal of Immunology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact